Prof Giagounidis presents his talk "How do TPO-R agonists impact the daily lives of chronic idiopathic thrombocytopenic purpura patients? Lessons from long-term studies" at EHA 2014.
GlaxoSmithKline fully provided for the costs of this symposium, honoraria for the Chairs & speakers and provided input into the symposium agenda/content.